How to Justify and Defend Your Startup Valuation (2026)

Last reviewed by Igor Shaverskyi on November 17, 2026

Say you've asked for a $24M pre-money valuation. The lead investor likes the company, but comes back at $20M. Most founders either give in or dig in, and both cost money. To defend your startup valuation, you need evidence an investor can check. You also need to know which terms you'd trade. Here's what investors accept, how to answer their pushback and when to concede.

How to Justify and Defend Your Startup Valuation (2026)

Back your number with evidence investors already trust. That means other offers in the round, traction against stage benchmarks, recent comparable rounds and a model they can check. Answer each pushback with one specific fact. If the gap stays, change the round size before the price. And take a lower, clean price over a higher one with heavy terms.

Key takeaways
  1. Investors price a round from two numbers: the stake their fund needs and the exit they believe in. Argue with those.
  2. Demand is the strongest evidence. A second term sheet moves a price faster than any spreadsheet.
  3. Pick comparable rounds from your own category. In early 2026, a non-AI Series A was valued at a median $55M, against $300M for AI model companies (Carta).
  4. A higher price with a 2x preference can leave you with less than a lower, clean price. Model the sale you're likely to get.
  5. If every offer lands in the same range after a full process, that range is your price.

How do VCs decide what valuation to offer?

Most VCs work back from two numbers: the stake they need and the exit they believe in. A fund aims for a set ownership in each deal, so your round size and their stake fix the price. Then they check whether your company could sell for enough to return a big multiple at that price.

Start with the stake. Across Carta's data for the second quarter of 2026, a seed round sold a median 19.4% of the company (Carta). A Series A sold 18.7%. So the price is mostly arithmetic: the money you raise divided by the stake the lead needs.

Say you raise $6M and the lead wants 20%. That fixes the post-money at $30M, so your pre-money is $24M. If they want a bigger stake, the same money buys it at a lower price. That's why arguing with your model rarely moves a lead. Change the inputs instead. If you can put $7.5M to work, raising it at a $30M pre-money still gives them 20%.

How VCs decide a valuation: the money raised divided by the stake the lead needs sets the post-money
How VCs decide a valuation: the round size and the lead's stake fix the price.

Then they check the exit. Say later rounds cut that 20% to 10% by the time you sell. To make ten times its money, the fund needs a $600M sale. A higher price raises that bar, so your evidence has to make a bigger exit believable. Our post-money guide walks through the maths. The valuation methods guide covers the VC method, and our valuation calculator runs it on your numbers.

What evidence do investors accept for a startup valuation?

Investors trust evidence they can check. The strongest is demand: another term sheet, or a lead ready to commit. Next come traction and growth against stage benchmarks, then recent comparable rounds in your category, then a driver-based model. Market size helps least, unless you build it bottom-up from real buyers and prices.

Startup valuation evidence, strongest first: demand, traction, comparable rounds, the model and market size
Startup valuation evidence, ranked by how much it moves an investor's price.

What convinces investors, and what doesn't.

EvidenceWhat convinces investorsWhat doesn't
Demand in the roundA second term sheet, or a lead ready to sign"Lots of interest" with no offers
Traction and growthRevenue, growth and retention against stage benchmarksOne great month, or vanity metrics
Comparable roundsFive recent rounds: same stage, category and regionHeadline mega-rounds from another category
The modelRevenue built from drivers: pipeline, conversion, priceA small share of a huge market
Market sizeBuyers you can reach, times your priceA top-down number from a market report

Demand beats every other argument, because it's the one an investor can't model away. In a $4M pre-seed round we prepared the pitch deck for, the founders had no product yet. They got 3 term sheets, and the round closed at a $40M valuation.

Comparables need care, because medians move fast. Wilson Sonsini's median seed pre-money was $35.0M in the first quarter of 2026 (Wilson Sonsini). In the second quarter, it was $23.0M. Category matters even more, since AI rounds now price differently. So pick five recent rounds that look like yours, and expect the investor to bring their own.

For traction, investors compare you with stage norms like growth, retention and burn multiple. Our Series A benchmarks and seed benchmarks list them with sources. In software, the multiple an investor will pay rises with growth and retention, as our SaaS multiples guide shows. The model is how they check the story. They want revenue built from drivers they can test, like pipeline, conversion and price.

How do you answer the most common valuation pushbacks?

Treat each pushback as a question about evidence. Work out what the investor is really worried about: comparables, growth, the model, their stake or the exit. Then answer with one specific fact. Don't argue with adjectives, and don't drop your price in the room. Ask what number they could back, and why.

These are the pushbacks we hear most in seed to Series B rounds. Here's what each usually means, and what to answer with.

Valuation pushbacks and how to answer them.

The investor saysWhat it usually meansAnswer with
"That's above market for your stage."They're comparing you with another category or quarterFive recent rounds like yours, with dates
"Your multiple is too high for your revenue."Your growth or retention doesn't earn the premium yetGrowth, net retention and burn multiple next to peers
"We don't believe the projections."The forecast isn't tied to driversA driver-based model with a base case they can test
"We need 20% to make this work."Their fund needs the stake, whatever the priceA bigger round at your price, if you can use it
"Your last round was priced too high."Your progress doesn't cover the step-upWhat changed since then: revenue, growth, burn
"Come back when you have more traction."They won't lead at this price, or at allAsk which milestone would change their answer
"We'll match your price with a 2x preference."They want downside cover for the higher priceA sale-by-sale comparison with a lower, clean price

Two of these need more than data. When a fund needs its stake, your lever is the round size, not the price. And when an investor offers your price with tougher terms, run the numbers before you answer. That's the next section.

Should you give on price or on terms?

Give a little on price before you give on terms that move money. A bigger option pool is a hidden price cut. A liquidation preference above 1x costs you in every modest sale. Pro rata rights for the lead cost little. Tranches can work when a clear milestone is a few months away.

Each term moves money or control in its own way. Here's what you'd give, what it costs you and how often it came up in 2026 deals.

Terms you can trade for price.

What you giveWhat it costs youHow common in 2026Worth it?
Pro rata rights for the leadLess room for new investors laterStandard for lead investorsUsually. Avoid super pro rata.
A bigger option pool, before the roundA price cut paid by existing shareholdersCommon in priced roundsOnly if your hiring plan needs it
A preference above 1xMoney in every small or mid-size saleRare: 1x in 95.8% of dealsRarely
Participating preferredA share of every sale, on top of their money back3% of preferred roundsAlmost never
A senior preferenceEarlier investors get paid after the new money16% of Series B and later roundsSometimes, from Series B
Milestone tranchesThe second payment, if you miss the milestone29.6% of life sciences dealsWhen a milestone is clear and close

Sources: Cooley, Q2 2026 (166 deals; preferences and tranches); Wilson Sonsini, first half of 2026 (participation and seniority). US deals handled by these firms.

Here's what that means in money, using the same round. The lead offers two deals. Offer A is a $20M pre-money with a standard 1x preference. Offer B is your $24M, with a 2x preference.

Two offers for the same $6M round: who gets what in a sale.

Sale priceOffer A: $20M pre-money, 1xOffer B: $24M pre-money, 2x
$25MInvestor $6.0M · others $19.0MInvestor $12.0M · others $13.0M
$50MInvestor $11.5M · others $38.5MInvestor $12.0M · others $38.0M
$100MInvestor $23.1M · others $76.9MInvestor $20.0M · others $80.0M

Waveup illustration. $6M invested in non-participating preferred, one class of preferred shares, no debt or fees. Others = founders, team and earlier investors.

Valuation negotiation example: what founders keep under a lower clean price vs a higher price with a 2x preference
Valuation negotiation example: below a sale of about $52M, the lower, clean price leaves founders more.

Offer B looks $4M better. It only pays off if you sell for more than about $52M. Below that, the 2x preference takes more than the higher price gives you. A higher headline also raises the bar for your next round, so a slow year can turn into a down round. Our liquidation preference guide shows 2x and participation at more sale prices.

The option pool is the quiet one. When the pool is carved out of the pre-money, existing shareholders pay for it, so your real price drops. Our term sheet guide shows by how much. Pro rata is usually the cheapest thing to give, since it only lets the lead keep its stake later. Our guide to pro rata rights has the maths.

When should you concede on valuation?

In our work, the signal is simple. If you've run a full process and every offer lands in the same range, that range is your price. Concede sooner if runway is short or the gap is small. And don't hold out for a number you'd struggle to grow into by the next round.

A full process means real coverage. In our work, a raise takes 35–40 investor meetings on average. If you've had that many and the offers cluster, more meetings rarely change the price. A shrinking runway does, and it moves the price down.

Before you dig in, check what the lower price really costs. In our experience, healthy dilution is about 10% at pre-seed, 15–20% at seed and 18–20% at Series A. If the lower offer keeps you inside that band, the fight is rarely worth a lost month. If it pushes you well past it, try a smaller round first. Our dilution guide has the round-by-round numbers.

Holding a price you can't grow into has a cost too. Down rounds were 12.1% of the deals Cooley worked on in the second quarter of 2026 (Cooley). When one comes, founders and employees take most of the hit.

Hold your number, or concede?

Hold your number if

  • You have a second term sheet, or a lead close to one
  • Recent rounds like yours support the price
  • Your growth and retention beat stage benchmarks
  • You can grow into the price by your next round
  • Your runway covers months more of talks

Concede if

  • Every offer lands in the same range
  • The gap is small and the investor is your first choice
  • The only route to your price is a 2x preference or participation
  • Your number would be hard to beat next round
  • You have under six months of runway

What does a professional valuation add?

A professional valuation gives you a range with the method behind each end. That means comparable rounds, a VC-method check on the exit and a model tied to your plan. Investors then argue with the evidence, not with you. Founders with a professional valuation raise at 20–30% higher valuations on average.

It also shows you early how far apart you and the market are. Learning that before your first meeting is cheaper than learning it from investors. Our business valuation work documents every comparable and assumption, so an investor's analyst can check each line.

What we see
We've built 500+ valuations, and the first surprise is usually the size of the gap. Our internal study based on 48 months of client work found that founder and market valuations often differ 2–3x. Close that gap with evidence before you pitch, not in the room.

Frequently asked questions

Should you tell investors your valuation first?
Not before there's real interest. Early on, say how much you're raising and what it gets you, and let the offers set the price. If an investor presses, give a range backed by recent comparable rounds.
Is a $35 million post-money valuation good for a seed round?
It's above the middle of the market. Carta's median for software seed rounds was a $24.3M valuation in the six months to July 2026 (Carta). It's good if real demand backs it, and risky if you can't grow into it by Series A.
What if every investor says your valuation is too high?
Then the market has priced you, at least for now. Take the range on offer, raise less at that price, or wait until your numbers catch up. Waiting only works if your runway covers it.
Can you use your 409A valuation to justify your round price?
No. It values your common stock to set option strike prices. Carta notes it will almost always come in below your last fundraising valuation. So it argues against your price, not for it.
Can you renegotiate your valuation after signing a term sheet?
Rarely. Once you sign, the no-shop stops you talking to other investors, so your best argument is gone. The investor can still reprice if due diligence finds a problem, so get your numbers clean before you sign.
Is a lower valuation from a better investor worth it?
Often, if the gap is modest. The right lead helps you hit the milestones that set your next price, and that round matters more than this one. Just check the lower price keeps your dilution in a healthy range.
Need a valuation you can defend in front of investors? We build the comparables, the exit check and the model behind your number. Business valuations start from $5,000, as a flat fee agreed before work starts.
Get a valuation quote

165 posts

Igor Shaverskyi

Partner & Co-founder, Waveup

Igor Shaverskyi is a Partner & Co-founder of Waveup, the London-based fundraising and growth advisory behind $3B+ raised for 600+ startups. He has 15 years in corporate finance and capital markets: he started as an investment banker at ICU, co-founded Waveup in 2014 and went on to create Waveup Copilot, Joltoo and n2labs. At Waveup he leads product development and the finance team. His perspectives on startup fundraising have been featured in TechCrunch.